Titan Pharmaceuticals announces non-compliance notice from Nasdaq

• Titan Pharmaceuticals (NASDAQ:TTNP) was notified by Nasdaq that it failed to file its Q3 report on time, violating listing requirements.
• The company has until January 21, 2025, to submit a plan to regain compliance. If Nasdaq accepts the plan, then Nasdaq may grant an